Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Adrenoleukodystrophy Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Adrenoleukodystrophy Drugsmarket, defines the market attractiveness level of Adrenoleukodystrophy Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Adrenoleukodystrophy Drugs industry, describes the types of Adrenoleukodystrophy Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Adrenoleukodystrophy Drugs market and the development prospects and opportunities of Adrenoleukodystrophy Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Adrenoleukodystrophy Drugs market in Chapter 13.
By Player:
Bluebird Bio Inc
Viking Therapeutics Inc
Pfizer Inc
ReceptoPharm Inc
Minoryx Therapeutics sl
SOM Biotech SL
MedDay SA
Applied Genetic Technologies Corp
By Type:
Biotin
DRX-065
DUOC-01
Lenti-D
MIN-102
OP-101
Others
By End-User:
Children
Adult
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Adrenoleukodystrophy Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Adrenoleukodystrophy Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Adrenoleukodystrophy Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Adrenoleukodystrophy Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Adrenoleukodystrophy Drugs Market Analysis and Outlook to 2022
-
7.1 Global Adrenoleukodystrophy Drugs Consumption (2017-2022)
-
7.2 United States Adrenoleukodystrophy Drugs Consumption (2017-2022)
-
7.3 Europe Adrenoleukodystrophy Drugs Consumption (2017-2022)
-
7.4 China Adrenoleukodystrophy Drugs Consumption (2017-2022)
-
7.5 Japan Adrenoleukodystrophy Drugs Consumption (2017-2022)
-
7.6 India Adrenoleukodystrophy Drugs Consumption (2017-2022)
-
7.7 South Korea Adrenoleukodystrophy Drugs Consumption (2017-2022)
8 Region and Country-wise Adrenoleukodystrophy Drugs Market Analysis and Outlook to 2028
-
8.1 Global Adrenoleukodystrophy Drugs Consumption Forecast (2022-2028)
-
8.2 United States Adrenoleukodystrophy Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Adrenoleukodystrophy Drugs Consumption Forecast (2022-2028)
-
8.4 China Adrenoleukodystrophy Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Adrenoleukodystrophy Drugs Consumption Forecast (2022-2028)
-
8.6 India Adrenoleukodystrophy Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Adrenoleukodystrophy Drugs Consumption Forecast (2022-2028)
9 Global Adrenoleukodystrophy Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Adrenoleukodystrophy Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biotin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global DRX-065 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global DUOC-01 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Lenti-D Consumption and Growth Rate (2017-2022)
-
9.1.5 Global MIN-102 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global OP-101 Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Adrenoleukodystrophy Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Children Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adult Consumption and Growth Rate (2017-2022)
10 Global Adrenoleukodystrophy Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Adrenoleukodystrophy Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biotin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global DRX-065 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global DUOC-01 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Lenti-D Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global MIN-102 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global OP-101 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Adrenoleukodystrophy Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adult Consumption Forecast and Growth Rate (2022-2028)
11 Global Adrenoleukodystrophy Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Adrenoleukodystrophy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Adrenoleukodystrophy Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Adrenoleukodystrophy Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Adrenoleukodystrophy Drugs Market Competitive Analysis
-
14.1 Bluebird Bio Inc
-
14.1.1 Bluebird Bio Inc Company Details
-
14.1.2 Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Product and Service
-
14.2 Viking Therapeutics Inc
-
14.2.1 Viking Therapeutics Inc Company Details
-
14.2.2 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Product and Service
-
14.3 Pfizer Inc
-
14.3.1 Pfizer Inc Company Details
-
14.3.2 Pfizer Inc Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Inc Adrenoleukodystrophy Drugs Product and Service
-
14.4 ReceptoPharm Inc
-
14.4.1 ReceptoPharm Inc Company Details
-
14.4.2 ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 ReceptoPharm Inc Adrenoleukodystrophy Drugs Product and Service
-
14.5 Minoryx Therapeutics sl
-
14.5.1 Minoryx Therapeutics sl Company Details
-
14.5.2 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Product and Service
-
14.6 SOM Biotech SL
-
14.6.1 SOM Biotech SL Company Details
-
14.6.2 SOM Biotech SL Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 SOM Biotech SL Adrenoleukodystrophy Drugs Product and Service
-
14.7 MedDay SA
-
14.7.1 MedDay SA Company Details
-
14.7.2 MedDay SA Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 MedDay SA Adrenoleukodystrophy Drugs Product and Service
-
14.8 Applied Genetic Technologies Corp
-
14.8.1 Applied Genetic Technologies Corp Company Details
-
14.8.2 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Adrenoleukodystrophy Drugs
-
Figure Adrenoleukodystrophy Drugs Picture
-
Table Global Adrenoleukodystrophy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Adrenoleukodystrophy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Adrenoleukodystrophy Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Adrenoleukodystrophy Drugs Consumption by Country (2017-2022)
-
Figure United States Adrenoleukodystrophy Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Adrenoleukodystrophy Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Adrenoleukodystrophy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Adrenoleukodystrophy Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Adrenoleukodystrophy Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Adrenoleukodystrophy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Adrenoleukodystrophy Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Adrenoleukodystrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Adrenoleukodystrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Adrenoleukodystrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Adrenoleukodystrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Adrenoleukodystrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Adrenoleukodystrophy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotin Consumption and Growth Rate (2017-2022)
-
Figure Global DRX-065 Consumption and Growth Rate (2017-2022)
-
Figure Global DUOC-01 Consumption and Growth Rate (2017-2022)
-
Figure Global Lenti-D Consumption and Growth Rate (2017-2022)
-
Figure Global MIN-102 Consumption and Growth Rate (2017-2022)
-
Figure Global OP-101 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Biotin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DRX-065 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DUOC-01 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lenti-D Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MIN-102 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global OP-101 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Adrenoleukodystrophy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Adrenoleukodystrophy Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Bluebird Bio Inc (Foundation Year, Company Profile and etc.)
-
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Product and Service
-
Table Viking Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Adrenoleukodystrophy Drugs Product and Service
-
Table ReceptoPharm Inc (Foundation Year, Company Profile and etc.)
-
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Product and Service
-
Table Minoryx Therapeutics sl (Foundation Year, Company Profile and etc.)
-
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Product and Service
-
Table SOM Biotech SL (Foundation Year, Company Profile and etc.)
-
Table SOM Biotech SL Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table SOM Biotech SL Adrenoleukodystrophy Drugs Product and Service
-
Table MedDay SA (Foundation Year, Company Profile and etc.)
-
Table MedDay SA Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedDay SA Adrenoleukodystrophy Drugs Product and Service
-
Table Applied Genetic Technologies Corp (Foundation Year, Company Profile and etc.)
-
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Product and Service
-
